{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:40:38Z","timestamp":1654191638672},"reference-count":8,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"name":"US Public Health Service","award":["139599","U54 DK106846"],"award-info":[{"award-number":["139599","U54 DK106846"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Summary:<\/jats:title>\n                  <jats:p>Chronic myelogenous leukemia (CML) is a stem cell disorder once considered an eventual death sentence upon progression to the terminal acute\/blastic cell phase, a terrible clinical outcome that has improved with the introduction of tyrosine kinase inhibitors. A major continuing problem with treating CML is the persistence of drug-resistant leukemia stem\/initiating cells (LS\/IC). In this issue of Blood Cancer Discovery, Silvestri and colleagues describe an incredibly in-depth mechanistic study using genetic and pharmacologic modulation of the miRNA MiR300 with and without treatment with activators of the serine-threonine protein phosphatase 2A (PP2A) in human cells. In vitro studies and in vivo mouse models of patient-derived xenografts were used to address the need to target LS\/ICs and restore immunity of impaired natural killer cells for attenuation of CML progression.<\/jats:p>\n                  <jats:p>See related article by Silvestri et al., p. 48.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1158\/2643-3249.bcd-20-0034","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T12:32:13Z","timestamp":1592569933000},"page":"13-15","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Players in Drug-Resistant Leukemia Stem\/Initiating Cells and Immunity in Patients with CML in Context of Oxygen Levels: Would Collecting\/Processing Cells in Hypoxia Offer Additional Information? A Next Frontier of Investigation"],"prefix":"10.1158","volume":"1","author":[{"given":"Hal","family":"Broxmeyer","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology and the NCI-Designated Comprehensive Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"2022060217121839300_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.BCD-19-0039","article-title":"Persistence of drug-resistant leukemic stem cells and impaired NK cell immunity in CML patients depend on MIR300 antiproliferative and PP2A-activating functions.","volume":"1","author":"Silvestri","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"2022060217121839300_bib2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.6004\/jnccn.2018.0071","article-title":"Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology","volume":"16","author":"Radich","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"2022060217121839300_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"2022060217121839300_bib4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3324\/haematol.2014.113852","article-title":"A hostel for the hostile: the bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Haematologica"},{"key":"2022060217121839300_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40778-018-0127-7","article-title":"Hypoxia signaling pathway in stem cell regulation: good and evil","volume":"4","author":"Huang","year":"2018","journal-title":"Curr Stem Cell Rep"},{"key":"2022060217121839300_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cell.2015.04.054","article-title":"Enhancing hematopoietic stem cell transplantation efficacy by mitigating oxygen shock","volume":"161","author":"Mantel","year":"2015","journal-title":"Cell"},{"key":"2022060217121839300_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOH.0000000000000144","article-title":"The importance of hypoxia and EPHOSS for collection and processing of stem and progenitor cells to understand true physiology\/pathology of these cells ex-vivo","volume":"22","author":"Broxmeyer","year":"2015","journal-title":"Curr Opin Hematopoiesis"},{"key":"2022060217121839300_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bcmd.2018.01.005","article-title":"Combinations of antioxidants and\/or of epigenetic enzyme inhibitors allow for enhanced collection of mouse bone marrow hematopoietic stem cells in ambient air","volume":"71","author":"Cai","year":"2018","journal-title":"Blood Cells Mol Dis"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/13\/3041678\/13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/13\/3041678\/13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:14:52Z","timestamp":1654190092000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/1\/1\/13\/35144\/Players-in-Drug-Resistant-Leukemia-Stem-Initiating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,19]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3249.bcd-20-0034","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}